Biotech · Private company
Hemanext
Track this companyFree. Adds Hemanext to your Dealase workspace and tells you when its record changes.
Clinical trials42 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- Hemanext OnePhase 2 · Whole Blood Donations and LeukoreductionClinicalTrials.gov · fetched Nov 12, 2026
- Hemanext Red Blood Cell Processing SystemPhase 2 · Whole Blood Donation and LeukoreductionClinicalTrials.gov · fetched Nov 12, 2026
- Conventional RBCsHematologic NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- Conventional RBCsSickle Cell AnaemiaClinicalTrials.gov · fetched Nov 12, 2026
- Hemanext ONE systemHematologic NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- Hemanext ONE SystemSickle Cell AnaemiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Hypoxic Red Blood Cells in Sickle Cell AnemiaNA · NOT_YET_RECRUITING · started Nov 30, 2026ClinicalTrials.gov NCT06743113 · fetched Nov 12, 2026
- Comparison of Hemanext ONE® System and Conventional Red Blood Cell TransfusionNA · ACTIVE_NOT_RECRUITING · started Nov 29, 2024ClinicalTrials.gov NCT06685848 · fetched Nov 12, 2026
- Clinical Investigation to Evaluate the Hemanext® Red Blood Cell Processing System for Extended Storage of Leukoreduced Red Blood CellsPHASE2 · WITHDRAWN · started Jul 1, 2020ClinicalTrials.gov NCT04418934 · fetched Nov 12, 2026
- Clinical Investigation to Evaluate the Hemanext® Oxygen Reduction System - Pivotal TrialPHASE2 · COMPLETED · started Nov 27, 2017ClinicalTrials.gov NCT03301779 · fetched Nov 12, 2026